Moderna enters R&D collaboration for mRNA gene-editing therapies
Wednesday, February 22, 2023 | Tag Cloud Tags: Covid, moderna, mrna, technology, Vaccine | Learn about our FREE SYNDICATION Service | Sign up for our Worthy Briefs! | Printer Friendly
(Worthy News) – Moderna Inc will collaborate with privately-owned Life Edit Therapeutics Inc under an agreement to discover and develop mRNA gene-editing therapies, the companies said on Wednesday.
The tie-up will apply Life Edit’s diverse collection of new technology for gene editing with the Moderna mRNA platform that was behind its COVID-19 vaccine.
Under the agreement, the companies will collaborate on research and preclinical studies funded by Moderna to develop curative therapies for some of the most challenging genetic diseases. [ Source: Reuters (Read More…) ]
Latest Worthy News
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.